Introduction: This study aimed to investigate the sensitivity to change over time of a new informantbased instrument to assess instrumental activities of daily living (IADL) during the course of dementia: the Amsterdam IADL Questionnaire Ó (A-IADL-Q). Methods: Participants (n 5 102) were patients and their informants who visited the Alzheimer Center of the VU University Medical Center. Linear mixed models with random effects were used to relate longitudinal change on the A-IADL-Q to diagnosis and to longitudinal change in cognitive measures. Results: We found longitudinal change on the A-IADL-Q to differ between diagnosis (P 5 .003), with dementia patients showing the fastest rate of decline (P , .001). In addition, we found longitudinal change on the A-IADL-Q to be related to longitudinal change in cognitive measures (global cognition: P , .001; memory: P 5 .024; executive functioning: P 5 .028). Discussion: Findings indicate the A-IADL-Q is sensitive to change over time in IADL functioning and can be used in evaluating treatment effects and assessing individual disease progress.
Introduction
Dementia is characterized by progressive cognitive decline and problems in performing instrumental activities of daily living (IADL) [1] . IADL are complex activities that are necessary to function independently, e.g. cooking [2] . Unfortunately, most of the questionnaires that measure IADL are not up-to-date and lack information about important measurement properties [3] . Therefore, Sikkes et al. [4] has developed the informant-based Amsterdam IADL Questionnaire Óa , which has shown to be a reliable and valid instrument in the evaluation of dementia [4, 5] .
An important property of questionnaires that measure patient reported or informant-based outcomes is the instruments' ability to measure change over time [6] . This property, described as "sensitivity to change" or "responsiveness", is considered an aspect of validity. In assessing IADL, measuring change is highly important because it enables clinicians to monitor disease progress of their patients and it enables the evaluation of potential treatment effects [7] . The longitudinal validity of the Amsterdam IADL Questionnaire (A-IADL-Q) is not yet known.
The main purpose of this study is to assess the ability of the A-IADL-Q to measure change in IADL functioning over time. To date, no gold standard for measuring change in IADL functioning is available. Therefore, the recommended approach to assess responsiveness is by construct validation [8] . Construct validity refers to the degree to which change in the scores on a measurement instrument is consistent with a priori formulated hypotheses [8] . Consequently, in this case these hypotheses should concern the relationship between change in scores on the A-IADL-Q and change indicated by other important indicators for change in daily functioning.
Using this approach, we first related longitudinal A-IADL-Q scores to diagnosis. We hypothesize that change on the A-IADL-Q differs between patients with a diagnosis of dementia, subjective memory complaints (SMC), and mild cognitive impairment (MCI). Because dementia is characterized by progressive decline while MCI patients and healthy elderly usually show only gradual or no decline, we expect the dementia group to show a more rapid rate of decline compared with the MCI and the SMC group.
Second, many studies reported an association between IADL functioning and cognitive decline. Early work on this relationship already demonstrated global cognitive functioning to be related to IADL functioning [9] . More recent studies assessing the relationship between IADL functioning and specific cognitive domains show attention/executive functioning [10] [11] [12] and memory to be the two most consistently associated domains [13, 14] . Based on these studies and because global cognition, memory, and attention/executive functioning are distinct cognitive constructs from a clinical perspective, we assessed the longitudinal relationship between IADL functioning and these three constructs separately. We hypothesize that change over time in A-IADL-Q scores is related to change over time in global cognition, memory, and attention/executive functioning.
Method

Participants
Participants in this study were patients and their informants who visited the Alzheimer Center of the VU University Medical Center for dementia screening between January 2012 and December 2012 and for follow up between December 2012 and May 2013.
Patients were excluded when their cognitive decline was due to other prominent medical conditions and when there were less than 6 months between baseline and follow-up measurements. In addition, for the relationship of the A-IADL-Q with diagnosis, patients who converted to dementia during the study were excluded to ensure homogeneity of groups. Also, patients who had more than 4 months in between the follow-up measurements of IADL and cognition were excluded for the analyses concerning, because change could have occurred. Informed consent was obtained from all patients and informants. The study was approved by the Medical Ethical Committee of the VU University Medical Center.
Measures
Dementia screening
All patients underwent a dementia screening at baseline. All dementia diagnoses were based on the consensus criteria for the different types of dementia [15] [16] [17] [18] . MCI was diagnosed according to Petersen criteria [19] . Patients who did not meet the criteria for dementia or MCI and did not have other neurological impairments were classified as "subjective memory complaints" (SMC).
Amsterdam IADL questionnaire
The A-IADL-Q is a computerized questionnaire aimed at measuring difficulties with complex daily activities. It is self-administered, completed by an informant of the patient. The A-IADL-Q consists of 70 items and for each item difficulty is rated on a 5-point scale. To optimize individual differences in premorbid IADL activities, items are tailored to individual responses (Fig. 1) [4] . When the patient did not perform the main activity more detailed items on this activity were skipped. The total score is calculated using an item response theory (IRT) method of scoring. IRT assumes that ordered-categorical item responses represent an underlying construct [20, 21] . In this case, the construct is IADL functioning, ranging from disability to ability. The total score is normally distributed (M 5 50, SD 5 10), with higher scores indicating better functioning [5] . Good construct validity, good content validity, high internal consistency (IRT reliability coefficient: .97), and high testretest reliability (87.9% of the items had kappa values ..60) were demonstrated previously [4, 5] .
Cognition b
Global cognitive ability was measured by the MiniMental State Examination (MMSE), a brief interview schedule that is widely used as a screening test for dementia [22, 23] .
To capture the complete domain of memory functioning, three widely used tests that measure different aspects of memory were selected. The following paper-and-pencil tests were administered: the Dutch version of the Rey Auditory Verbal Learning Task (RAVLT) [24] that measures verbal learning and memory, the Visual Association Task (VAT) that is a brief learning task based on imagery mnemonics [25] , and the Digit Span task of the Wechsler Adult Intelligence Scale III. This task comprises Digits Forward and Digits Backward, measuring immediate recall and working memory, respectively [26] . Both tests consist of digit sequences that need to be repeated by the patient, either in forward or in backward order.
To capture the complete domain of attention/executive functioning, three widely used tests that measure different aspects of executive functioning were selected. The following paper-and-pencil timed tests were administered: the Stroop Color-Word Task, which measures cognitive flexibility and sensitivity to interference [26] , the Trail Making Test (TMT) A and B, which measures attention and b More detailed information on the measurement properties of the neuropsychological tests and the included subscores can be found in the web-only Supplemental Material.
cognitive flexibility/set shifting [26] , and the Dutch version of the Letter Fluency of the Controlled Oral Word Association Test measuring verbal fluency, which is part of executive functioning [26, 27] .
Procedure
Measurements were obtained at baseline and follow-up. The amount of time between baseline and follow-up varied per subject, with a minimum of 6 months. During the baseline visit to the Alzheimer Center patients underwent a standardized dementia screening, while the informant completed the A-IADL-Q. A research assistant provided instructions and stayed available to answer questions if needed.
At follow-up, patients were recruited at their extensive follow-up meeting, their appointment with a neurologist, via telephone, or via e-mail. Patients recruited at the center underwent a cognitive assessment, while the informant completed the A-IADL-Q. Patients recruited via telephone or email were requested to complete the A-IADL-Q electronically from home. This approach was also used when informants were not available at follow-up.
Statistical analyses
Sociodemographic factors of all participants were examined and differences between diagnostic groups were tested using Pearson's chi square, Fisher's exact test, or independent ANOVA with post hoc procedures if appropriate.
To test our first hypothesis, the relationship between diagnosis and our longitudinal A-IADL-Q data were assessed using a linear mixed model with random effects. Linear mixed models incorporate a random intercept and a random slope, which allows for individual variability in initial A-IADL-Q scores and the rate of decline in A-IADL-Q scores [28] . The interaction between diagnosis and time represented the relationship between diagnosis and change in A-IADL-Q scores over time.
To test our second hypothesis, we examined the relationship between IADL and our three cognitive constructs: global cognition, memory and attention/executive functioning. Memory and attention/executive functioning were assessed using several neuropsychological tests, which cannot be directly compared with each other. Therefore, CFA with strict factorial invariance, suitable for longitudinal data, was used to derive one score (the latent variable) from these different tests to represent the cognitive domain. Detailed information on this method can be found in Oort [29] and Oort et al. [30] . We assessed overall goodness-of-fit using the maximum likelihood estimation method. A satisfactory goodness-of-fit is indicated by the magnitude of the following fit indices: a nonsignificant chi square test, the comparative fit index (CFI) . .95, the root mean square error of approximation (RMSEA) , .06, and the standardized root mean square residual (SRMR) , .08 [31] . In summary, for each cognitive domain, we performed CFA to derive one latent score that represented this domain. To be able to use this score as a good representative, a onefactor model with satisfactory fit indices needed to be confirmed.
After this, the longitudinal relationship between change in the three constructs and change in IADL ratings was analyzed by linear mixed models. Also, we incorporated the cross-sectional effect to assess baseline relationships. We expected a decline in cognitive ability to be related to a decline in A-IADL-Q score over time for all three cognitive constructs.
All models were corrected for age of the patient at baseline, gender and education level [32, 33] . Statistical analyses were performed using SPSS version 20.0 for Windows (SPSS Inc., Chicago, IL) and Mplus. The significance level was set at P , .05.
Results
Fig . 2 shows the subject flow from baseline to follow-up. A total of 208 persons were eligible for inclusion, of which 102 actually participated in the study. Main reasons for dropout were untraceable informants, the baseline informant not being available at follow-up, and refusal of the patient or informant and nonresponse. Mean time between baseline and follow-up was 1.6 years (SD 5 0.9). Table 1 presents baseline patient and informant characteristics of the total sample and of the diagnosis groups SMC, MCI, and dementia. We found no significant differences in patient characteristics between groups. Age of the informants differed between groups F(2,87) 5 4.41, P 5 .024, but was not significantly different on post hoc testing. Overall, most informants were spouses of the patient; however, there was a slight difference between groups (P 5 .021). Mean IADL score for the total sample at baseline was 51.0 (SD 5 15.7) and 42.8 (SD 5 20.2) at follow-up.
Differences between diagnoses in change over
Linear mixed modeling showed that the interaction between diagnosis and time, which models the relationship between diagnosis and change in A-IADL-Q scores over time, was found to be significant (P 5 .003). As illustrated in Fig. 3 , this means that the rate of decline in A-IADL-Q scores differed between diagnoses. The A-IADL-Q score of the dementia group declined with a rate of 7.35 points per year, 95% confidence interval [5.01, 9 .69], P , .001. This was significantly faster compared with the rate of decline in the SMC and the MCI groups (P 5 .007) (Fig. 3) . Also, we found an effect of diagnosis on A-IADL-Q scores (P , .001) and of time (P 5 .010) on A-IADL-Q scores.
Relationship between change in A-IADL-Q scores and change in cognition
Two subjects were excluded because more than 4 months passed by between IADL and cognitive follow-up measures being taken, bringing the sample size to 100.
Results of linear mixed modeling showed a longitudinal effect of MMSE on change in IADL scores over time (P , .001). The rate of decline in MMSE score was related to the rate of decline in IADL score. As shown in Table 2 , a decrease of one point on the MMSE was associated with a decrease of 3.11 points on the A-IADL-Q. Also, we found a cross-sectional effect: a lower baseline MMSE score was associated with a lower score on the A-IADL-Q (P , .001). Fig. 4 illustrates the relationship between individual trajectories of the A-IADL-Q score over time and change in MMSE score. To depict this relationship, we arranged subjects into quartiles of change in MMSE score. The trajectories of subjects in the first quartile, with the largest amount of decline on the MMSE, suggest decreasing IADL scores over time. Those in the fourth quartile improved on the MMSE and, although there is individual variability, their trajectories suggest stability or even a slight increase of IADL scores over time.
To test the relationship between change in IADL and change in memory functioning we used CFA to construct one score that represented scores on the three different neuropsychological measures. It was assumed that the distribution of this new memory scale was standard normal (M 5 0, SD 5 1). Three subjects had missing values for all measures and were therefore excluded bringing the sample size to 97. As described, we used the fit indices of the chi-square test, CFI, RMSEA, and SRMR to assess goodness-of-fit. CFA showed that a model including all memory tests did not have satisfactory fit indices and did not show to measure one underlying factor (latent variable). We therefore subsequently explored different combinations of memory tests subscores to construct a model that satisfied both criteria. This led us to the final model incorporating "total score of the RAVLT", "VAT A total score", and "Digit Span backwards total score". Models that also included one of the other variables (delayed recall of the RAVLT, VAT B and Digit Span forwards) did not show a one-factor model or had unsatisfactory fit indices. Of the final model, the SRMR was slightly too high (SRMR 5 .108), but the other fit indices indicate a satisfactory fit: CFI 5 .978, RMSEA 5 .033, c 2 (17) 5 18.77, P 5 .342. Detailed information on model parameters can be found online in the Supplemental Material.
After this, we assessed the longitudinal relationship between memory and A-IADL-Q scores. As shown in Table 2 , we found a longitudinal effect of memory on change in IADL score over time. A decline in memory was significantly related to a decline in IADL score over time (P 5 .024). A decline of one point on the memory scale was associated with a decline of 7.6 points on the A-IADL-Q. Also, we found a cross-sectional effect of memory on IADL score, indicating that a lower baseline memory score was related to a lower IADL score (P , .001).
To test the relationship between our longitudinal IADL and the executive functioning domain, we used the same procedure as for the memory domain. We explored several Abbreviations: SMC, subjective memory complaints; MCI, mild cognitive impairment. NOTE. Data are presented as mean (SD), median (interquartile range), or n (%). The diagnosis group labeled as 'other' (n 5 10) is included in the characteristics for the total sample, but not presented separately. Differences between groups were tested using independent analysis of variance, Pearson's chi square, or Fisher's exact test.
*Education according to Verhage's classification, ranging from 1 (low) to 7 (high) [41] . models with different combinations of the executive functioning tests to construct a model that measured only one underlying factor and also provided a good fit to the data. However, it was not possible to construct a model that satisfied both criteria.
To provide at least a rough indication of the relationship we aimed to assess, we used data of the TMT B, which measures executive functioning. Attention was therefore not assessed. Because 48 patients did not complete the TMT B, sample size was 54. Using linear mixed modeling with random effects, we found a longitudinal effect of change in executive functioning on change in IADL score, F(1,57.24) 5 5.12, P 5 .028. An increase of one minute of time spent on the TMT B is associated with a decline of 3.81 points on the A-IADL-Q (Table 2 ). In addition, we found a cross-sectional effect of executive functioning on IADL score (P 5 .003). A higher amount of time spent on the TMT B is associated with a lower score on the A-IADL-Q.
Discussion
In this longitudinal validation study, we confirmed that change in scores on the A-IADL-Q over time differed between diagnoses, with the most rapid IADL decline in patients with dementia. Also, we confirmed that decline in scores on the A-IADL-Q was related to decline in global cognition, memory, and executive functioning. NOTE. B parameters are unstandardized. Standardized Bs are based on standardized B5 B ! SD(X i )/SD(Y), with X as independent variable and Y as dependent variable, SD 5 SE/O(n). For the MMSE and memory, higher scores indicate better performance, for executive functioning a lower score indicates better performance. Executive functioning is measured by Trail Making Test B, where performance is given by the amount of minutes required for completion. After the previous validation studies of Sikkes et al. [4, 5] , where good construct validity, good content validity, and high internal consistency were demonstrated, this is the first study on the sensitivity to change of the A-IADL-Q. Also, this is the first study to assess the responsiveness of an IADL instrument by the construct approach, which is the recommended approach in the absence of a gold standard [8] . The ability of other IADL questionnaires to measure change over time has been reviewed by Sikkes et al. [3] . They state that for most instruments, adequate psychometric information to rate responsiveness is lacking. To our knowledge, only one study directly addressed the sensitivity to change of an IADL instrument [34] . However, the authors used a global impression of change given by a clinician as a gold standard to define the sensitivity and specificity of the instrument. Besides that, they only provided correlations between change scores on the IADL questionnaire and cognitive measures instead of using linear mixed models [35] . Because there is no gold standard for change in IADL, it might be questioned whether the results in this study are specific enough to draw conclusions on the questionnaire's sensitivity to change in IADL functioning.
Our findings showed that the A-IADL-Q was able to measure change in IADL functioning. First, we demonstrated that dementia patients showed a faster rate of decline in A-IADL-Q score over time compared with MCI and SMC patients. This longitudinal relationship between diagnosis and change in IADL scores was addressed in only a few other studies. One study by Farias et al. [36] was aimed at assessing the longitudinal relationship between change in IADL and change in cognition. Comparable with our results, they found that the annual rate of IADL change differed between cognitively normal individuals, MCI patients and patients with dementia, with the last group showing the fastest rate of decline [36] . An interesting finding in our study is the individual variability in the MCI and SMC groups. Based on previous findings it is anticipated that part of the MCI patients will convert to dementia over time [37] . Possibly, patients in the SMC and MCI group who show a rapid rate of IADL decline are the patients who will convert to dementia in the future.
Second, we demonstrated that change in A-IADL-Q score was related to change in global cognition, memory, and executive functioning. For the composition of the cognitive domains, we encountered problems in deriving one score from the different neuropsychological tests, possibly due to unsatisfactory psychometric properties of the used instruments b . Previous comparable studies only assessed how a cognitive domain measured at baseline could predict decline in functional ability [11, 12] . One study that also specifically examined the longitudinal relationship between change in cognition and change in IADL functioning is the study by Farias et al. [36] . In line with our results, the authors demonstrated a relationship between change in IADL functioning and change in memory and executive functioning. These results support the possibility of measuring changes in the construct IADL over time.
The following limitations should be taken into account. First, subjects with a dementia diagnosis were overrepresented in our sample, probably due to selection bias. However, our MCI and SMC groups behaved as expected based on clinical prognosis and we can therefore assume that our results are representative for the different groups. Another potential limitation could be that we treated follow-up IADL and cognitive measures that were taken at different moments in time as if they were measured on the same date. Although we limited time difference to 4 months, a change in functioning could have occurred between the two measurements. Yet, this would have only underestimated the relationship between the trajectory of change in cognition and the trajectory of change in IADL. Because we did find a significant relationship between IADL and cognition, we feel even more confident in the robustness of this finding. Third, in this study the mood of the patient and informant, which could potentially have an effect on measures of daily functioning, was not assessed. However, a previous study by Sikkes et al. [5] showed the correlation of the A-IADL-Q with depressive symptoms of both the patient and the informant to be low. Therefore, do not expect these factors to have a significant influence on A-IADL-Q scores in this study.
The main strength of this study is that, to our knowledge, this is the first study to assess the sensitivity to change of an IADL instrument by the construct approach. In the absence of a gold standard, this is the recommended method to assess responsiveness [8] . It provides additional proof that a true change in IADL is measured. Another strength is that this study addressed the relationship over time of the A-IADL-Q with several different longitudinal measures. The fact that the A-IADL-Q showed to be sensitive to changes in all of those measures underlines the ability of the A-IADL-Q to measure change over time. Furthermore, we included not only patients with dementia to assess responsiveness, but also individuals with MCI and SMC. This strengthens the generalizability of the results to a memory clinic setting and suggests that the A-IADL-Q could be applicable as a measure in broader populations as well.
Assessing changes in functional ability over time is essential for intervention studies because functional measures are directly related to caregiver burden [38] and are of specific relevance to the quality of life of the patient [39] . Additionally, they show less learning effects compared with cognitive ones [38] and results are less influenced by education, gender, and age [40] . Therefore, the A-IADL-Q can be of great relevance as an outcome measure in future randomized clinical trials using various approaches and may be of more use than other IADL instruments where the responsiveness has not been supported [3] . Besides the use in intervention studies, it can be a highly useful instrument for clinicians to assess disease progression and deterioration in the ability to perform daily activities of their patients in early and later stages of dementia.
In conclusion, in this longitudinal validation study of the A-IADL-Q, we demonstrated the sensitivity to changes of the A-IADL-Q. The results indicate that the A-IADL-Q may be a useful tool for evaluating treatment effects and for assessing individual disease progress. Future research could investigate whether sensitivity to change is observed equally in all items of the A-IADL-Q. Also because validation of a questionnaire is an ongoing process, future studies should examine the responsiveness of the A-IADL-Q in other clinical or cultural populations. In addition, further research on the longitudinal relationship of the A-IADL-Q with biomarkers of Alzheimer's disease pathology could take the longitudinal validation of the A-IADL-Q to a next level.
